Iran experiences in providing access and management of ...
Transcript of Iran experiences in providing access and management of ...
![Page 1: Iran experiences in providing access and management of ...](https://reader033.fdocuments.us/reader033/viewer/2022060408/6294fe085369ee034b57a7a5/html5/thumbnails/1.jpg)
1
![Page 2: Iran experiences in providing access and management of ...](https://reader033.fdocuments.us/reader033/viewer/2022060408/6294fe085369ee034b57a7a5/html5/thumbnails/2.jpg)
Iran experiences in providing access and management of medicine at the time of war and sanctions
Prof. Mostafa Ghanei, Director General of Biotechnology Development Council (BDC)
![Page 3: Iran experiences in providing access and management of ...](https://reader033.fdocuments.us/reader033/viewer/2022060408/6294fe085369ee034b57a7a5/html5/thumbnails/3.jpg)
7th World Health Summit Meeting2019
Prof. Mostafa Ghanei. Internist PulmonologistBaqiyatallah University of Medical Sciences
![Page 4: Iran experiences in providing access and management of ...](https://reader033.fdocuments.us/reader033/viewer/2022060408/6294fe085369ee034b57a7a5/html5/thumbnails/4.jpg)
Pharmaceutical Industry Strategies: Past - Present
Past 1946
Dr. AbidiLaboratory Establishment
1958
Tolid DarouCompanyEstablishment
1963
Darou PakhshCompanyEstablishment
1964
PfizerCompany BranchEstablishment
1967
CyanamidCompany BranchEstablishment
1979
Islamic Revolution
1980
Iraq-IranImposed War
1981
Compilation of National Drug List
1988
Privatization ofPharmaceuticalIndustry
2003
NationalPharmaceuticalPolicy Compilation
2015
NationalPharmaceutical Policies Revision
present
BiotechnologyProducts Export toDifferent Countries
Pre Pre Post Post
![Page 5: Iran experiences in providing access and management of ...](https://reader033.fdocuments.us/reader033/viewer/2022060408/6294fe085369ee034b57a7a5/html5/thumbnails/5.jpg)
Sales Trend of the Top Five Therapeutic Chemical Groups
5
![Page 6: Iran experiences in providing access and management of ...](https://reader033.fdocuments.us/reader033/viewer/2022060408/6294fe085369ee034b57a7a5/html5/thumbnails/6.jpg)
Availability Trends of Cancer Drugs: Sanctions
6
![Page 7: Iran experiences in providing access and management of ...](https://reader033.fdocuments.us/reader033/viewer/2022060408/6294fe085369ee034b57a7a5/html5/thumbnails/7.jpg)
Policies and Strategies
Co-operation with the Food and Drug Administration infacilitating joint venture between producing companies
Policy making to reduce the cost of production in the country
Encouraging export-centered companies
Guiding tax exemptions of knowledge-based companies tothe research, innovation, and exporting sectors ofcompanies
7
![Page 8: Iran experiences in providing access and management of ...](https://reader033.fdocuments.us/reader033/viewer/2022060408/6294fe085369ee034b57a7a5/html5/thumbnails/8.jpg)
Iran’s Pharmaceutical Industry at a Glance
Generic and Brand-Generic Systems
More than 15000
Pharmacists
More than 186 Trading Companies
About 36 Distributing Companies
More than 107 Manufacturing
Companies
National self-sufficiency at 96% FP and
50% API
Possessing Higher than 9
billion USD Drug Economy
Strict Qualitative and Quantitative Controls on the Pharmaceutical
Industry
Possessing "National Drug
Policy“ more than Two Decades
8
![Page 9: Iran experiences in providing access and management of ...](https://reader033.fdocuments.us/reader033/viewer/2022060408/6294fe085369ee034b57a7a5/html5/thumbnails/9.jpg)
Iran Position in Biotechnology Drugs
• Total No. of biotechnology Drugs developed in world : 160
• Total No. of biotechnology Drugs produced in Iran : 22
• Iran’s position in Asia: 2nd
9
Biotechnology Drugs Producing Countries in Asia
No. of Produced Drugs in Asia
Japan 31Iran 22India 12
South Korea 10China 10
![Page 10: Iran experiences in providing access and management of ...](https://reader033.fdocuments.us/reader033/viewer/2022060408/6294fe085369ee034b57a7a5/html5/thumbnails/10.jpg)
10